NYSE:GEN

Genesis Healthcare Stock Forecast, Price & News

$0.51

-0.02 (-3.77 %)

(As of 11/27/2020 12:00 AM ET)

Add

Compare

Today's Range

$0.49

Now: $0.51▼

$0.54

50-Day Range

$0.42

MA: $0.48▼

$0.54

52-Week Range

$0.40

Now: $0.51▼

$1.86

Volume720,716 shs

Average Volume869,546 shs

Market Capitalization$85.07 million

P/E Ratio2.32

Dividend YieldN/A

Beta1.7

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of April 23, 2020, it provided inpatient services through a network of approximately 400 skilled nursing facilities and assisted/senior living communities in 25 states; and supplied rehabilitation and respiratory therapy to approximately 1,200 healthcare locations in 44 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.

Beat the Market (BTM) Rank^™

2.0 Analyst's Opinion

Consensus Rating
Genesis Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $0.57, Genesis Healthcare has a forecasted upside of 11.8% from its current price of $0.51.
Amount of Analyst Coverage
Genesis Healthcare has only been the subject of 1 research reports in the past 90 days.

2.7 Community Rank

Outperform Votes
Genesis Healthcare has received 455 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Genesis Healthcare has received 389 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Genesis Healthcare has received 53.91% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote “Outperform” if you believe GEN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Genesis Healthcare does not currently pay a dividend.
Dividend Growth
Genesis Healthcare does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Genesis Healthcare insiders have not sold or bought any company stock.
Percentage Held by Insiders
35.20% of the stock of Genesis Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 15.71% of the stock of Genesis Healthcare is held by institutions.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Genesis Healthcare is 2.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.86.
Price to Earnings Ratio vs. Sector
The P/E ratio of Genesis Healthcare is 2.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.20.

Overall Beat the Market Rank^™

1.36 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Skilled nursing care facilities

Sub-IndustryN/A

SectorMedical

Current SymbolNYSE:GEN

Previous SymbolNYSE:SKH

CUSIPN/A

CIK1351051

Webwww.genesishcc.com

Phone610-444-6350

Employees55,000

Debt

Debt-to-Equity RatioN/A

Current Ratio0.90

Quick Ratio0.90

Price-To-Earnings

Trailing P/E Ratio2.32

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$4.57 billion

Price / Sales0.02

Cash Flow$0.96 per share

Price / Cash Flow0.53

Book Value($6.57) per share

Price / Book-0.08

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$14.62 million

Net Margins1.07%

Return on Equity-5.06%

Return on Assets1.18%

Miscellaneous

Outstanding Shares166,797,000

Market Cap$85.07 million

Next Earnings Date3/15/2021 (Estimated)

OptionableOptionable

$0.51

-0.02 (-3.77 %)

(As of 11/27/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

How has Genesis Healthcare's stock price been impacted by COVID-19 (Coronavirus)?

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GEN stock has decreased by 56.0% and is now trading at $0.51.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Genesis Healthcare?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Genesis Healthcare or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Genesis Healthcare?

Wall Street analysts have given Genesis Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Genesis Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Genesis Healthcare.

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) announced its earnings results on Monday, November, 9th. The company reported ($0.55) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.53. The firm earned $938.65 million during the quarter. Genesis Healthcare had a net margin of 1.07% and a negative return on equity of 5.06%.
View Genesis Healthcare's earnings history.

What price target have analysts set for GEN?

1 analysts have issued twelve-month price targets for Genesis Healthcare's stock. Their forecasts range from $0.57 to $0.57. On average, they anticipate Genesis Healthcare's share price to reach $0.57 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price.
View analysts' price targets for Genesis Healthcare.

Are investors shorting Genesis Healthcare?

Genesis Healthcare saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 1,150,000 shares, an increase of 21.4% from the September 30th total of 947,500 shares. Based on an average trading volume of 1,230,000 shares, the short-interest ratio is currently 0.9 days. Approximately 2.1% of the company's stock are sold short.
View Genesis Healthcare's Short Interest.

Who are some of Genesis Healthcare's key competitors?

Some companies that are related to Genesis Healthcare include The Ensign Group (ENSG), National HealthCare (NHC), National HealthCare (NHC), Five Star Senior Living (FVE), Diversicare Healthcare Services (DVCR), Regional Health Properties (RHE) and Regional Health Properties (RHE).
View all competitors.

What other stocks do shareholders of Genesis Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN), Government Properties Income Trust (GOV), Advanced Micro Devices (AMD), Bausch Health Companies (BHC) and Canopy Growth (CGC).

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:

Mr. George V. Hager Jr., CEO & Director (Age 64, Pay $941.61k)
Mr. Thomas DiVittorio, Exec. VP & CFO (Age 52, Pay $525k)
Mr. Paul David Bach, COO & Exec. VP (Age 61, Pay $525k)
Mr. Michael Scott Sherman, Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer (Age 51, Pay $380k)
Dr. JoAnne Susan Reifsnyder R.N., Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 61, Pay $425k)
Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 65)
Mr. James W. Tabak, Sr. VP of Admin. & Gov. Affairs (Age 61)
Ms. Lori Mayer, VP of Investor Relations, Brand Management & Marketing Communications
Mr. Larry Baider, Sr. VP of People Strategy & Operations
Mr. Jason Hadley Feuerman, Sr. VP of Strategic Devel. & Managed Care

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Who are Genesis Healthcare's major shareholders?

Genesis Healthcare's stock is owned by many different retail and institutional investors. Top institutional investors include Acadian Asset Management LLC (1.25%), Squarepoint Ops LLC (0.16%), First Trust Advisors LP (0.09%) and Jane Street Group LLC (0.08%). Company insiders that own Genesis Healthcare stock include George V Hager, Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio.
View institutional ownership trends for Genesis Healthcare.

Which institutional investors are selling Genesis Healthcare stock?

GEN stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC. Company insiders that have sold Genesis Healthcare company stock in the last year include George V Hager, Jr, Joanne Susan Reifsnyder, Paul David Bach, Stephen Scott Young, and Thomas Divittorio.
View insider buying and selling activity for Genesis Healthcare.

Which institutional investors are buying Genesis Healthcare stock?

GEN stock was purchased by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Squarepoint Ops LLC, and First Trust Advisors LP.
View insider buying and selling activity for Genesis Healthcare.

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $0.51.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $85.07 million and generates $4.57 billion in revenue each year. Genesis Healthcare employs 55,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings